Olstein Capital Management L.P. boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 17.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 109,000 shares of the company’s stock after acquiring an additional 16,000 shares during the quarter. Olstein Capital Management L.P. owned about 0.09% of Henry Schein worth $7,543,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Cromwell Holdings LLC lifted its holdings in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Versant Capital Management Inc increased its position in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after acquiring an additional 335 shares in the last quarter. City State Bank purchased a new position in shares of Henry Schein in the fourth quarter worth approximately $55,000. Farther Finance Advisors LLC raised its holdings in shares of Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after acquiring an additional 346 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.14% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on Henry Schein
Henry Schein Price Performance
NASDAQ HSIC opened at $74.97 on Friday. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The stock’s 50-day moving average is $72.99 and its two-hundred day moving average is $71.01. The firm has a market cap of $9.35 billion, a P/E ratio of 30.85, a price-to-earnings-growth ratio of 2.04 and a beta of 0.89. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue was up .4% compared to the same quarter last year. During the same period last year, the business earned $1.32 EPS. On average, analysts anticipate that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- Technology Stocks Explained: Here’s What to Know About Tech
- Bloom Energy: Powering the Future With Decentralized Energy
- Health Care Stocks Explained: Why You Might Want to Invest
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.